Google
 
Google

World Stem Cell Summit 2010

Monday, November 10, 2008

Orcrist's new stem cell mobilizer

 

View this message online

Hello manoj kumar valluru,

Last week the Canadian company Orcrist Bio was issued a patent, #7,446,100, covering the use of stem cell mobilization and immuno-correction after chemotherapy using specific molecular weight fragments of hyaluronic acid.  Given the high-profile management team of the company, combined with this relatively innocuous product, we predict Orcrist will be a potent force in the regenerative medicine area. 

Another patent of interest, #7,445,931, assigned to Bresagen (now Novocell), teaches methods of generating high-purity neuronal precursors from pluripotent stem cells using various ceramides.  There is currently an exponential rise in publications dealing with ceramides controlling signal transduction events, therefore this patent will be interesting to place into context of more recent biological findings. 

Interesting publications last week, Kondo et al describe that adipose regenerative cells (sound familiar?) induce angiogenesis through SDF-1 dependent manner, dependent on endogenous stem cell mobilization.  Also Chang et al reported bone marrow derived mesenchymal stem cells having some degree of efficacy in a porcine model of diabetes.  Speaking of mesenchymal stem cells, Osiris signed a development deal with Genzyme in which Osiris will commercialize Prochymal and Chondrogen (bone marrow allowgeneic MSC products) in the US and Canada, and Genzyme will commercialize in Rest of World.  Genzyme will make an upfron $130 million payment to Osiris plus milestone and royalties estimated to be >1 billion dollars.

 


Methods for cell mobilization using in vivo treatment with hyaluronan (HA)
 
 
Patent Number: 7,446,100

Stem cell mobilization is important commercially/medically from several angles.  Firstly, donors of hematopoietic stem cells usually prefer to have their bone marrow resident stem cells "mobilized" so as to enter the blood and be collected from blood as opposed to having holes drilled in their iliac crest.  Secondly, for some...[Read More]

Ask a question OR leave your comments.

 


  Angiogenesis requires endogenous stem cells

Monday November 3rd, 2008 @ 21:47:44 EST

Nagoya, Japan -

Implantation of various stem cell populations into an ischemic muscle has been demonstrated to induce neovascularization both in animal studies, and in clinical trials.  Some people believe that the therapeutic angiogenesis may be occuring by differentiation...[Read More]

Ask a question OR leave your comments.

Read more StemCellPatents.com News
 

 

Stem Cells World Congress

The Stem Cell Meeting 

RMSC 2008 World Congress (2-4 December 2008)
The 3rd Annual Stem Cells World Congress (20-22 January 2009)
The Stem Cell Meeting (March 2009)

 


  RECENTLY ADDED PATENTS  
  Compositions and methods for enrichment of neural stem cells using ceramide analogs (7,445,931)
Assignee | Inventor | Ask a question OR leave your comments
 
  Methods for cell mobilization using in vivo treatment with hyaluronan (HA) (7,446,100)
Assignee | Inventor | Ask a question OR leave your comments
 
  Culturing human embryonic stem cells in medium containing pipecholic acid and gamma amino butyric acid (7,442,548)
Assignee | Inventor | Ask a question OR leave your comments
 
  Combined effects of nutrients on proliferation of stem cells (7,442,394)
Assignee | Inventor | Ask a question OR leave your comments
 
  Method for enhancing engraftment of cells using mesenchymal progenitor cells (7,442,390)
Assignee | Inventor | Ask a question OR leave your comments
 
  Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium (7,439,064)
Assignee | Inventor | Ask a question OR leave your comments
 
  Polypeptide having an activity to support proliferation or survival of hematopoietic stem or progenitor cells (7,439,332)
Assignee | Inventor | Ask a question OR leave your comments
 
  Compositions for allogeneic cell therapy (7,435,592)
Assignee | Inventor | Ask a question OR leave your comments
 
  CXCR4 antagonist treatment of hematopoietic cells (7,435,718)
Assignee | Inventor | Ask a question OR leave your comments
 
  Methods for the culture of human embryonic stem cells on human feeder cells (7,432,104)
Assignee | Inventor | Ask a question OR leave your comments
 
  View all 1352 Stem Cell Patents on StemCellPatents.com  


  LATEST NEWS  
  Mesenchymal Stem Cells Treating Pig Diabetes
6 days ago
 
  Angiogenesis requires endogenous stem cells
6 days ago
 
  CTLA-4 Inhibition in Hematological Malignancies
November 3rd
 
  Potentiating Mesenchymal Stem Cells for Cardiac Regeneration
October 26th
 
  Sensitizing CML Precursors to GVL
October 19th
 
  Read more news on StemCellPatents.com  


  LATEST JOBS POSTS  
  View the StemCellPatents.com Job Board

 

Thanks again for your help in supporting StemCellPatents.com.


We welcome your comments and suggestions! Tell us here.

Media Partnerships (NEW)






------------------------------------------------------------
To unsubscribe, click here.
Delivered: Monday November 10th, 2008 @ 14:35:02 EST
 
Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time